← back to search

John Cursio

Chicago Department of Public Health ·
Area of research
Otorhinolaryngology · Immunology
Research interest
Research interests include Head and Neck Cancer Studies, Complement system in diseases, Cancer Genomics and Diagnostics, and Frailty in Older Adults.
h-index
20
citations
1,194
works
98
NIH funding
primary concept
email

Recent publications

Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Stratified Chemoradiation Therapy in HPV-Negative Head and Neck Cancer
JAMA Oncology 2025cited by 21position: middledoi
Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus–Associated Oropharyngeal Cancer
Clinical Cancer Research 2025cited by 7position: middledoi
Response and outcomes of patients with IDH1/2- mutated accelerated/blast-phase myeloproliferative neoplasms
Blood Neoplasia 2025cited by 3position: middledoi
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV<sup>+</sup> Oropharyngeal Cancer
JAMA Oncology 2024cited by 43position: middledoi
Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era
Blood Advances 2024cited by 27position: middledoi
Optimization of older adults by a geriatric assessment–guided multidisciplinary clinic before CAR T-cell therapy
Blood Advances 2024cited by 17position: middledoi
Neoadjuvant nivolumab, paclitaxel, and carboplatin followed by response-stratified chemoradiation in locoregionally advanced HPV negative head and neck squamous cell carcinoma (HNSCC): The DEPEND trial.
Journal of Clinical Oncology 2023cited by 14position: middledoi
Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience
Oral Oncology 2021cited by 30position: middledoi
Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical center
Oncotarget 2019cited by 24position: middledoi
Discharge disposition as an independent predictor of readmission among patients hospitalised for community-acquired pneumonia
International Journal of Clinical Practice 2017cited by 19position: middledoi
Improving Pain Relief in Elder Patients (I‐PREP): An Emergency Department Education and Quality Intervention
Journal of the American Geriatrics Society 2016cited by 15position: middledoi
Lifestyle Intervention and Cardiovascular Disease Risk Reduction in Low-Income Hispanic Immigrant Women Participating in the Illinois WISEWOMAN Program
Journal of Community Health 2014cited by 24position: middledoi
Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A 20-Year Review from the Southern Network on Adverse Reactions (SONAR)
Seminars in Thrombosis and Hemostasis 2012cited by 87position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Daniel J. Haraf · University of Illinois Chicago5 papers (2021–2025)Nishant Agrawal · Institute of Chartered Financial Analysts of India5 papers (2021–2025)Ari J. Rosenberg · University of Chicago5 papers (2021–2025)Everett E. Vokes · University of Illinois Chicago5 papers (2021–2025)Zhen Gooi · University of Chicago5 papers (2021–2025)Jeffrey Chin · University of California, San Francisco5 papers (2021–2025)Elizabeth A. Blair · Elgin Community College5 papers (2021–2025)Aditya Juloori · University of Chicago5 papers (2021–2025)Alexander T. Pearson · RWTH Aachen University5 papers (2021–2025)Mark W. Lingen · University of Chicago4 papers (2021–2025)Daniel Thomas Ginat · University of Chicago4 papers (2021–2025)Nicole A. Cipriani · University of Chicago4 papers (2021–2025)Evgeny Izumchenko · University of Chicago4 papers (2021–2025)Olga Pasternak-Wise · University of Chicago3 papers (2023–2025)Anand Patel · University of Illinois Chicago2 papers (2024–2025)Hannah Johnston · University of Chicago2 papers (2024–2025)Frederick S. Jones · Atrium Health Wake Forest Baptist2 papers (2024–2025)Timothy S. Oh · Wake Forest University2 papers (2024–2025)Evan C. Chen · Boston Medical Center2 papers (2024–2025)Olatoyosi Odenike · Leipzig University2 papers (2024–2025)